ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Envigo Nabs New Equity Financing

by Ann M. Thayer
July 27, 2015 | APPEARED IN VOLUME 93, ISSUE 30

Envigo, the English company soon to be formed from the merger of Huntingdon Life Sciences and Harlan Laboratories, has received a commitment for up to $125 million from a group of institutional investors. The nonclinical contract research firm will use the money for future growth initiatives and strategic investments. With the official launch of Envigo in a few months’ time, it will have about 3,800 employees and annual revenues of nearly $500 million.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment